Borkenstein Andreas F, Borkenstein Eva-Maria
Private Practice, Privatklinik der Kreuzschwestern Graz, Kreuzgasse 35, 8010-Graz, Austria.
J Ophthalmol. 2018 May 15;2018:3843098. doi: 10.1155/2018/3843098. eCollection 2018.
The purpose of this prospective analysis was to evaluate the patient and surgeon satisfaction levels after using a fully preloaded acrylic, hydrophobic, monofocal "premium" IOL in pseudoexfoliation syndrome.
42 eyes of twenty-eight patients with progressed cataract formation and pseudoexfoliation syndrome (PXF) or pseudoexfoliation glaucoma and best corrected distance visual acuity (BCDVA) between 0.30-1.00 logMAR were enrolled. After a detailed preexamination, they underwent phacoemulsification and implantation of the acrylic, hydrophobic, heparin-coated, single-piece, monofocal intraocular lens (CT LUCIA 601P, Zeiss, Germany) with 360° square edge and ultraclear purity aspheric ZO optic. We evaluated the visual performance of the IOL and the patient satisfaction. We also evaluated the intraoperative handling of the injector and the behavior of the IOL in these complicated cases (PXF).
The BCDVA increased from mean 0.48 logMAR (range 0.30-1.00 logMAR) preoperatively to -0.05 ± 0.13 logMAR postoperatively. The mean IOL power was 23.5 D (range 16.5-27.5 D). The target refraction using the Haigis formula within ±0.5 D was reached by 92.9% (=39) and by 100% (=42) within 1.0 D of all cases, respectively. Patient satisfaction was very high, and no halos or glare were reported in any case. The fully preloaded injector system enabled an easy IOL preparation and safe implantation.
Our results show that the implantation of the fully preloaded CT LUCIA 601P (Zeiss, Germany) is safe and enhances OR workflow in complicated cases as pseudoexfoliation. In these cases, an adapted approach (special preoperative, intraoperative, and postoperative regime) with considering possible complications is necessary to achieve best outcomes.
本前瞻性分析旨在评估在假性剥脱综合征中使用完全预装的丙烯酸酯、疏水、单焦点“高端”人工晶状体(IOL)后患者和手术医生的满意度水平。
纳入28例患有进展期白内障合并假性剥脱综合征(PXF)或假性剥脱性青光眼且最佳矫正远视力(BCDVA)在0.30 - 1.00 logMAR之间的患者的42只眼。经过详细的术前检查后,他们接受了超声乳化手术,并植入了具有360°方形边缘和超清晰纯净非球面ZO光学部的丙烯酸酯、疏水、肝素涂层、单片式、单焦点人工晶状体(CT LUCIA 601P,德国蔡司公司)。我们评估了IOL的视觉性能和患者满意度。我们还评估了注射器在术中的操作以及IOL在这些复杂病例(PXF)中的表现。
BCDVA从术前的平均0.48 logMAR(范围0.30 - 1.00 logMAR)提高到术后的 -0.05±0.13 logMAR。平均IOL屈光度为23.5 D(范围16.5 - 27.5 D)。分别有92.9%(=39)和100%(=42)的病例在使用Haigis公式计算的目标屈光度±0.5 D和1.0 D范围内达到目标。患者满意度非常高,且在任何病例中均未报告有光晕或眩光。完全预装的注射器系统使IOL的准备工作轻松且植入安全。
我们的结果表明,植入完全预装的CT LUCIA 601P(德国蔡司公司)是安全的,并且在假性剥脱等复杂病例中可提高手术室工作流程效率。在这些病例中,采用考虑到可能并发症的适应性方法(特殊的术前、术中和术后方案)对于获得最佳结果是必要的。